Difference between revisions of "Chlorambucil (Leukeran)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
(Created page with "==General information== Class/mechanism: Nitrogen mustard, alkylating agent. Interferes with DNA replication and induces apoptosis through accumulation of p53 in the cytosol and ...")
 
m (Text replacement - "please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [https://online.lexi.com/lco/action/login UpToDate Lexidrug], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information" to "please refer to your preferred pharmacopeias or the prescribing information")
 
(41 intermediate revisions by 5 users not shown)
Line 1: Line 1:
 
==General information==
 
==General information==
−
Class/mechanism: Nitrogen mustard, alkylating agent. Interferes with DNA replication and induces apoptosis through accumulation of p53 in the cytosol and downstream activation of the apoptosis promoter Bax.<ref name="insert">[http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/010669s032lbl.pdf Chlorambucil (Leukeran) package insert]</ref><ref>[http://hemonc.org/docs/packageinsert/chlorambucil.pdf Chlorambucil (Leukeran) package insert (locally hosted backup)]</ref>
+
Class/mechanism: Nitrogen mustard, alkylating agent. Interferes with DNA replication and induces apoptosis through accumulation of p53 in the cytosol and downstream activation of the apoptosis promoter Bax.<ref name="insert">[https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=967ed3ff-d99b-41e8-b768-dfb586d3d9a6 Chlorambucil (Leukeran) package insert]</ref><ref>[[:File:Chlorambucil.pdf | Chlorambucil (Leukeran) package insert (locally hosted backup)]]</ref>
 
<br>Route: PO
 
<br>Route: PO
 
<br>Extravasation: n/a
 
<br>Extravasation: n/a
  
−
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the package insert<ref name="insert"></ref>.
+
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias or the prescribing information.<ref name="insert"></ref>  
 +
 
 +
==Diseases for which it is established==
 +
*[[Follicular lymphoma]]
 +
 
 +
==Diseases for which it is used==
 +
*[[B-cell lymphoma of mucosa-associated lymphoid tissue]]
 +
*[[Chronic lymphocytic leukemia]]
 +
*[[Classical Hodgkin lymphoma]]
 +
*[[Mantle cell lymphoma]]
 +
*[[Marginal zone lymphoma]]
 +
*[[Waldenström macroglobulinemia]]
 +
 
 +
==Diseases for which is was used==
 +
*[[Breast cancer - historical|Breast cancer]]
 +
*[[Ovarian cancer - historical|Ovarian cancer]]
 +
*[[Testicular cancer - historical|Testicular cancer]]
  
 
==Patient drug information==
 
==Patient drug information==
 +
*[https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=967ed3ff-d99b-41e8-b768-dfb586d3d9a6 Chlorambucil (Leukeran) package insert]<ref name="insert"></ref>
 +
*[https://chemocare.com/druginfo/chlorambucil.aspx Chlorambucil (Leukeran) patient drug information (Chemocare)]<ref>[https://chemocare.com/druginfo/chlorambucil.aspx Chlorambucil (Leukeran) patient drug information (Chemocare)]</ref>
 
*[http://www.uptodate.com/contents/chlorambucil-patient-drug-information Chlorambucil (Leukeran) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/chlorambucil-patient-drug-information Chlorambucil (Leukeran) patient drug information (UpToDate)]</ref>
 
*[http://www.uptodate.com/contents/chlorambucil-patient-drug-information Chlorambucil (Leukeran) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/chlorambucil-patient-drug-information Chlorambucil (Leukeran) patient drug information (UpToDate)]</ref>
  
−
==Regimens==
+
==History of changes in FDA indication==
−
Standard format will be:
+
*1957-03-18: Initial FDA approval
−
<br><acronym (if any)> <generic drug1, generic drug2, generic drug3, etc.> (disease)
+
*2003-11-13 (oldest label available at Drugs @ FDA): indicated in the treatment of [[Chronic lymphocytic leukemia|chronic lymphatic (lymphocytic) leukemia]], [[:Category:Lymphomas|malignant lymphomas including lymphosarcoma, giant follicular lymphoma, and Hodgkin's disease]]. It is not curative in any of these disorders but may produce clinically useful palliation. ''(No supporting studies are cited)''
 +
==History of changes in EMA indication==
 +
*1956-09-14: EURD
 +
==Also known as==
 +
*'''Brand names:''' Chloraminophene, Chlorambusil, Chlorobutin, Chlorbutin, Leukeran, Linfoxan
  
 
==References==
 
==References==
 
<references/>
 
<references/>
 +
 +
[[Category:Drugs]]
 +
 +
[[Category:Oral medications]]
 +
 +
[[Category:Nitrogen mustards]]
 +
[[Category:Alkylating agents]]
 +
 +
[[Category:Chronic lymphocytic leukemia medications]]
 +
[[Category:Classical Hodgkin lymphoma medications]]
 +
[[Category:Follicular lymphoma medications]]
 +
[[Category:MALT lymphoma medications]]
 +
[[Category:Mantle cell lymphoma medications]]
 +
[[Category:Marginal zone lymphoma medications]]
 +
[[Category:Waldenström macroglobulinemia medications]]
 +
 +
[[Category:Breast cancer medications (historic)]]
 +
[[Category:Ovarian cancer medications (historic)]]
 +
[[Category:Testicular cancer medications (historic)]]
 +
 +
[[Category:FDA approved in 1957]]
 +
[[Category:EMA approved in 1956]]
 +
[[Category:WHO Essential Cancer Medicine]]

Latest revision as of 01:01, 29 June 2024

General information

Class/mechanism: Nitrogen mustard, alkylating agent. Interferes with DNA replication and induces apoptosis through accumulation of p53 in the cytosol and downstream activation of the apoptosis promoter Bax.[1][2]
Route: PO
Extravasation: n/a

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias or the prescribing information.[1]

Diseases for which it is established

Diseases for which it is used

Diseases for which is was used

Patient drug information

History of changes in FDA indication

History of changes in EMA indication

  • 1956-09-14: EURD

Also known as

  • Brand names: Chloraminophene, Chlorambusil, Chlorobutin, Chlorbutin, Leukeran, Linfoxan

References

  1. ↑ 1.0 1.1 1.2 Chlorambucil (Leukeran) package insert
  2. ↑ Chlorambucil (Leukeran) package insert (locally hosted backup)
  3. ↑ Chlorambucil (Leukeran) patient drug information (Chemocare)
  4. ↑ Chlorambucil (Leukeran) patient drug information (UpToDate)
Retrieved from "https://hemonc.org/w/index.php?title=Chlorambucil_(Leukeran)&oldid=87285"